Strategic Partnerships Genova Diagnostics has recently acquired Cell Science Systems and partnered with Ki Health to expand gut health testing through retail pharmacies, presenting a clear opportunity to cross-sell complementary diagnostics, lab services, and consumer-facing testing programs to pharmacy networks and integrated care partners.

Executive Growth With a new Chief Commercial Officer appointed in 2026, there is a heightened emphasis on commercial strategy, channel development, and enterprise partnerships, creating a favorable window for enterprise sales outreach to health systems, large clinics, and specialty networks seeking advanced diagnostic capabilities.

Innovative Offerings Launches such as the Alzheimer's Assessment and Fatty15 Test demonstrate Genova’s focus on niche, high-value diagnostic assays, signaling opportunities to upsell to existing clients and pursue collaborations with wellness programs, neurology practices, and nutritionally oriented care models.

Scale & Reach As a global specialty laboratory with over 125 diagnostics and a CLIA-accredited footprint, Genova serves diverse care settings, enabling territory-based sales strategies to hospitals, academic centers, and large multi-site clinics requiring scalable, test-rich lab partnerships.

Data‑Driven Value Color-coded, actionable reporting and clinician education resources position Genova as a value partner that can be positioned to healthcare networks seeking outcomes-focused lab services, integration with EHRs, and physician-friendly decision support to drive adoption of comprehensive testing programs.